Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Cholangiocarcinoma
×
Capecitabine
×
Clear all
Filters
3
NCT06037980
2025-02-17
PURITY
Gruppo Oncologico del Nord-Ovest
Phase 2/3
Recruiting
300 enrolled